Sedana Medical AB (publ)
STO:SEDANA

Watchlist Manager
Sedana Medical AB (publ) Logo
Sedana Medical AB (publ)
STO:SEDANA
Watchlist
Price: 19.9 SEK 4.96% Market Closed
Market Cap: 2B SEK
Have any thoughts about
Sedana Medical AB (publ)?
Write Note

Sedana Medical AB (publ)
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sedana Medical AB (publ)
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Sedana Medical AB (publ)
STO:SEDANA
Pre-Tax Income
-kr56.5m
CAGR 3-Years
-4%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Pre-Tax Income
kr1.7B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Pre-Tax Income
kr237.1m
CAGR 3-Years
137%
CAGR 5-Years
104%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Pre-Tax Income
kr188.7m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
16%
Getinge AB
STO:GETI B
Pre-Tax Income
kr3.3B
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Pre-Tax Income
kr640m
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
N/A
No Stocks Found

Sedana Medical AB (publ)
Glance View

Market Cap
2B SEK
Industry
Health Care

Sedana Medical AB is a medical technology company, which engages in the development, manufacture, and sale of medical devices and drug development for future projects around AnaConDa. The company is headquartered in Danderyd, Stockholm. The company went IPO on 2017-06-21. The company develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.

SEDANA Intrinsic Value
14.22 SEK
Overvaluation 29%
Intrinsic Value
Price

See Also

What is Sedana Medical AB (publ)'s Pre-Tax Income?
Pre-Tax Income
-56.5m SEK

Based on the financial report for Sep 30, 2024, Sedana Medical AB (publ)'s Pre-Tax Income amounts to -56.5m SEK.

What is Sedana Medical AB (publ)'s Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-37%

Over the last year, the Pre-Tax Income growth was 1%. The average annual Pre-Tax Income growth rates for Sedana Medical AB (publ) have been -4% over the past three years , -37% over the past five years .

Back to Top